What’s new at our area hospitals
The Valley Hospital A NEW WAY TO CLEAR ARTERIES
The Valley Hospital in Ridgewood was the first hospital in New Jersey to use a recently approved device that offers a minimally-invasive approach to the treatment of peripheral artery disease (PAD) in the upper leg, a serious and common condition associated with an increased risk for heart attack and stroke.
The procedure uses drug-coated balloons, a new type of medical device developed to treat PAD in the upper legs once medical management has failed. Vascular surgeons Dr. Joshua Bernheim, Dr. Daniel Char, director of vascular surgery, and Dr. Mitul S. Patel successfully performed the first procedures at the hospital.
“The new drug-coated balloons represent a real game changer for patients,” Char says. “Other minimally invasive procedures have been associated with the need for repeat procedures within six to 12 months because the plaque build-up returns to the vessel wall. The medication that coats this balloon and is left behind following the procedure reduces this risk for repeat procedures.”
Affecting an estimated eight to 12 million people in the U.S., PAD is a debilitating disease that occurs when arteries become narrowed or blocked by plaque build-up, restricting blood flow. The pain can be described as dull, causing a heaviness or tightness in the muscles, but often will stop when the person is at rest.
Drug-coated balloons are designed to help restore blood flow by reopening blocked arteries and delivering a medication to the artery wall that clinical studies have shown helps keep the artery open longer than other available therapies. During the procedure, an inflated balloon pushes the plaque away to create a channel for blood flow. The medication on the balloon surface is absorbed into the artery wall. The balloon is then removed with only the medication left behind.
Hackensack University Medical Center
ROBOT KILLS GERMS AND BACTERIA
Hackensack University Medical Center is employing the germ-zapping Xenex robot to reduce the risk of health care associated infections. Using a powerful ultraviolet light, the Xenex robot is designed to destroy viruses, bacteria and bacterial spores lingering on surfaces.
“We have always been committed to finding innovative ways to stay ahead of the curve in clinical excellence and technology,” Kunle Modupe, vice president of hospitality services at HackensackUMC, says. “This collaboration combines both in an effective and safe manner.”
The robot, named Violet by HackensackUMC’s Environmental Services team, emits ultraviolet light designed to destroy viruses, bacteria and bacterial spores on surfaces within minutes. Without contact or chemicals, the robot is credited with killing microorganisms, including Clostridium difficile (C. diff), norovirus, influenza, and staph bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA).
The robot works alone, room-by-room, on an automated sequence of cycles. It contains no mercury or hydrogen peroxide and is described as the only green technology used in automated room disinfection.